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finding of the clinical and the environ-
mental isolate (1,2). The existence of
MATa in nature is also supported by
recent studies designed to established
the origin of the serotype AD strains
(4,5). These studies demonstrated that
AD strains were diploid or aneuploid
hybrids derived from a fusion of
serotype Aand D parents and that sev-
eral of them were harboring a
serotype AMATa locus. These hybrid
strains have been found fairly often in
Europe (9,10).
The finding of this isolate provides
evidence of the pathogenic role of this
rare mating type, emphasizes the crit-
ical function of molecular genetic
tools in the characterization of C. neo-
formans  populations, and represents
an advance in knowledge of this fun-
gal species whose genome is undergo-
ing identification by a worldwide
research team. 
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Severe Acute
Respiratory
Syndrome:
Relapse? Hospital
Infection? 
To the Editor: Severe acute respi-
ratory syndrome (SARS) is an emerg-
ing infectious disease worldwide, and
relapsing SARS is a major concern.
We encountered a 60-year-old woman
who was admitted to the Princess
Margaret Hospital in Hong Kong on
March 29, 2003, with a fever of 39°C,
chills, cough, malaise, and sore throat
for 2 days before admission. She had
no history of travel within 2 weeks of
admission. She also had no close con-
tact with patients who had a diagnosis
of suspected or confirmed SARS.
Chest radiograph on admission indi-
cated consolidation over the right
middle zone. In accordance with the
diagnostic criteria proposed by the
World Health Organization (WHO),
this patient’s condition was diagnosed
as SARS in view of her symptoms,
temperature, and chest radiograph
findings (1).
Standard microbiologic investiga-
tions to exclude common respiratory
virus and bacterium for community-
acquired pneumonia, including
Mycobacterium tuberculosis, were
negative in our patient. Reverse tran-
scriptase–polymerase chain reaction
(RT-PCR) of nasopharyngeal aspirate
samples was negative for coronavirus
twice. The coronavirus antibody titer
was less than 1/25. The patient was
initially treated with oral clar-
ithromycin (500 mg twice a day) and
intravenous amoxycillin-clavulanate
combination (1.2 g three times a day).
Despite the negative evidence for
coronavirus infection, she was treated
with intravenous ribavirin (24 mg/kg
once a day) and hydrocortisone (10
mg/kg once a day) after 48 hours of
antibiotics therapy (2). The patient’s
symptoms were relieved, and she
remained afebrile 3 days after admis-
sion. Tolerance for medication was
good except for a moderate degree of
hemolytic anemia (her hemoglobin
level dropped to 9.1 g/dL) and
hypokalemia that developed during
treatment. On day 15, the chest radi-
ography was clear. The patient was
discharged after 3 weeks of hospital
stay. 
The patient attended outpatient
clinic on day 35, complaining of exer-
tional dyspnea, low-grade fever, and
malaise since her discharge. Her chest
radiography showed extensive shad-
owing. Computer tomographic scan
of the thorax indicated widespread
ground-glass shadowing in both lung
fields, which was especially promi-
nent at left lower and lingular lobes.
1180 Emerging Infectious Diseases • Vol. 9, No. 9, September 2003
LETTERSEmerging Infectious Diseases • Vol. 9, No. 9, September 2003 1181
LETTERS
Her hemoglobin level had dropped
further to 8.4 g/dL. Sputum culture
yielded substantial growth of methi-
cillin-sensitive Staphylococcus aureus
and  Pseudomonas aeruginosa. RT-
PCR results of throat and nasal swabs
were positive twice for coronavirus,
but coronavirus cultures from these
areas were negative. One month after
onset, her coronavirus antibody titer
was 200. In view of possible relapse
of SARS, she was treated with oral
ribavirin (1,200 mg/day) and
lopinavir (133.3 mg/day)/ritonavir
(33.3 mg) combination (3 capsules
twice a day) in addition to intravenous
piperacillin/tazobactam combination.
The patient was afebrile, and symp-
toms improved 3 days after admis-
sion. Serial chest radiograph showed
gradual resolution of shadowing.
Subsequent RT-PCR and sputum cul-
ture were negative.
This case illustrates several impor-
tant issues regarding problems of
infection control, diagnosis, and man-
agement of SARS. As the definition
of SARS is nonspecific, patients with
upper respiratory infection or commu-
nity-acquired pneumonia could be
mislabeled as having SARS.
Accommodating confirmed SARS
patients and patients mislabeled as
having SARS in the same facility may
be disastrous. Unfortunately, isolating
every single case is impossible, par-
ticularly when a large number of
patients are admitted. Our patient may
have acquired the disease after admis-
sion since she was placed in the same
ward with other patients confirmed to
have SARS. For this reason, special
cohorting of SARS patients with
closely related signs and symptoms
should be strictly implemented at
admission. Since fever is the most
common feature of SARS, isolating
febrile cases with respiratory or gas-
trointestinal symptoms may be appro-
priate. Even patients with fever alone
should be quarantined since the other
symptoms of SARS may not be clini-
cally obvious. Secondly, the sensitivi-
ty of diagnosing a coronavirus infec-
tion on admission is only 32% to 50%
by nasopharyngeal RT-PCR test (3,4).
Many infected cases will be missed as
a result. Our patient may have had a
relapse of disease during her second
admission, although she had positive
RT-PCR and antibody surge only 1
month after onset. However, we could
not conclude whether the first RT-
PCR on admission was a false nega-
tive or whether the patient acquired
coronavirus infection in the hospital.
Our study showed that sensitivity for
diagnosing coronavirus infection
could be increased by performing RT-
PCR on samples from different parts
of the body (4). Unfortunately, these
samples were not taken from our
patient. Furthermore, the chest infec-
tion with organisms recovered from
her sputum could be the sole reason
for her second admission, especially
when her immune system was weak-
ened by the administration of a high-
dose steroid. The presence of genetic
material for coronavirus from her
nasal cavity and throat might not sug-
gest that the virus is active. The
absence of coronavirus growth in this
patient might indicate that the virus is
no longer viable, although the culture
technique itself might not be sensitive
enough to justify this claim.
Therefore, further refinement of the
diagnostic techniques for SARS is
essential, especially for diagnosis dur-
ing early onset. Thirdly, giving treat-
ment to a patient without a legitimate
diagnosis may be inappropriate, espe-
cially when the treatment carries sub-
stantial adverse effects, as illustrated
in our patient, and a universally
accepted therapy has not been avail-
able. Whether lopinavir/ritonavir
combination is the key to a cure
remains to be clarified, despite the
satisfactory response that we
observed, since the clinical and radio-
logic improvement in our patient
might be the natural course of the dis-
ease. 
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Remembering
Jonathan M. Mann
in a World Ajar
September 2003 marks the
anniversary of the deaths of Jonathan
M. Mann and his wife Mary Lou
Clements aboard Swiss Air flight 111,
which crashed off the shore of Peggy’s
Cove, Nova Scotia, 5 years ago.
Although Jonathan and I were both
members of the Council of State and